4DMedical is trading at A$2.10, down 12.86%, with no clear company announcement or confirmed catalyst identified for the November 4 decline.
- In its November 2 ASX response, the company said it knew of no undisclosed information and pointed to increased short interest as a likely explanation for recent trading.
- Recent coverage describes volatility after disputed executive bonus proposals were defeated at the AGM, but does not establish that this caused the November 4 fall.